Immunotherapy for Multiple Myeloma

Despite therapeutic advances over the past decades, multiple myeloma (MM) remains a largely incurable disease with poor prognosis in high-risk patients, and thus new treatment strategies are needed to achieve treatment breakthroughs. MM represents various forms of impaired immune surveillance charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Hideto, Ishibashi, Mariko, Sunakawa, Mika, Inokuchi, Koiti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966649/
https://www.ncbi.nlm.nih.gov/pubmed/31842518
http://dx.doi.org/10.3390/cancers11122009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966649/
https://www.ncbi.nlm.nih.gov/pubmed/31842518
http://dx.doi.org/10.3390/cancers11122009

Ejemplares similares